21 April 2022 - Beth Vanstone doesn’t want anyone else to have to fight for access to life saving medications. ...
13 April 2022 - A pill to treat COVID-19 appears to be the country’s best hope, outside of vaccines and ...
4 April 2022 - CADTH has launched consultations on a proposed process for non-sponsored reimbursement reviews and a streamlined process ...
5 April 2022 - CADTH is pleased to share Ahead of the Curve: Shaping Future-Ready Heath Systems, the agency's new ...
22 March 2022 - Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia. ...
2 March 2022 - Public formulary and program coverage makes AJOVY® accessible to more migraine patients across Canada. ...
28 February 2022 - The ALS Society of Canada Cana today marks Rare Disease Day 2022 by calling on the ...
24 February 2022 - Private insurance coverage across Canada exceeds 90%. ...
22 February 2022 - The Patented Medicine Prices Review Board released today the third and final part in the Alignment ...
16 February 2022 - Canada needs an approach that balances pricing considerations with the need to encourage investment, foster innovation, and ...
15 February 2022 - The provincial government is covering costs for risdiplam, or Evrysdi, the medication used to treat a severe ...
10 February 2022 - Following the signing of an agreement between AbbVie and the pan-Canadian Pharmaceutical Alliance, Quebec, Saskatchewan, and ...
5 February 2022 - The province is the latest jurisdiction to adopt a program that will require patients to switch ...
4 February 2022 - CADTH is pleased to announce it is expanding its expertise in the management of pharmaceuticals in ...
28 January 2022 - Lilly Canada is pleased to announce that as of 31 January 2022, Baqsimi (glucagon nasal powder) ...